These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14976270)

  • 1. Heart failure in a district general hospital: are target doses of beta-blockers realistic?
    Mehta PA; McDonagh S; Poole-Wilson PA; Grocott-Mason R; Dubrey SW
    QJM; 2004 Mar; 97(3):133-9. PubMed ID: 14976270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].
    Kawashiro N; Matsuda N; Endo Y; Uchida Y; Kasanuki H
    J Cardiol; 2006 May; 47(5):229-37. PubMed ID: 16764329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
    Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
    Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
    Krum H; Ninio D; MacDonald P
    Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titration of carvedilol in elderly heart failure patients.
    Lawless CE; Tamlyn T; Shah R; Karim FM; Khan E; Creech S
    Am J Geriatr Cardiol; 2005; 14(5):230-5. PubMed ID: 16247281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
    Metra M; Torp-Pedersen C; Swedberg K; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Lutiger B; Scherhag A; Lukas MA; Charlesworth A; Poole-Wilson PA
    Eur Heart J; 2005 Nov; 26(21):2259-68. PubMed ID: 16040619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure.
    Piccirillo G; Luparini RL; Celli V; Moisè A; Lionetti M; Marigliano V; Cacciafesta M
    Am J Cardiol; 2000 Dec; 86(12):1392-5, A6. PubMed ID: 11113424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
    Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
    Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study.
    Aurich-Barrera B; Wilton LV; Shakir SA
    Drug Saf; 2009; 32(1):43-54. PubMed ID: 19132804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
    Kotlyar E; Keogh AM; Macdonald PS; Arnold RH; McCaffrey DJ; Glanville AR
    J Heart Lung Transplant; 2002 Dec; 21(12):1290-5. PubMed ID: 12490274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of commencing Carvedilol in elderly patients with heart failure in a routine outpatient clinic.
    Owen A
    Eur J Heart Fail; 2000 Sep; 2(3):287-9. PubMed ID: 10938490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.